The US Food and Drug Administration's (FDA) decision not to approve midomafetamine-assisted therapy (MDMA-AT) for ...

Lykos Therapeutics filed an application for FDA approval of its version of MDMA-assisted therapy for PTSD in February 2024.

In a previous blog on the use of psychedelics to treat mental health disorders, we reported that the US Food and Drug Administration (FDA) ...

then FDA approval of psychedelics may be a matter of “when” not “if.” MAPS Executive Director Rick Doblin has been working to legalize MDMA for PTSD since the 1980's as ... [+] well as ...

Some researchers call MDMA an “empathogen” or a “feeling enhancer.” PTSD affects between 9 million to 13 million people annually in the U.S., and no novel treatments for the condition have been ...

Two small studies submitted to the FDA suggested combining MDMA with talk therapy led to significant easing of PTSD symptoms. Antidepressants are now the only FDA-approved drugs for PTSD ...

MDMA came close to becoming medicine on Friday, but it missed the mark. The Food and Drug Administration declined to approve what would have been the first psychedelic drug used for the treatment ...